US Patent 12110338 Site-specific antibody-drug conjugation through glycoengineering
Patent 12110338 was granted and assigned to Genzyme on October, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 17, 2021
0
Date of Patent
October 8, 2024
0
Patent Applicant
Patent Application Number
17404412
0
Patent Citations
•••
Patent Inventor Names
Robert Miller
0
Qun Zhou
0
Clark Pan
0
Diego Gianolio
0
Pradeep Dhal
0
James Stefano
0
Huawei Qiu
0
Bo Chen
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 12110338 Site-specific antibody-drug conjugation through glycoengineering
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.